| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 08/07/2007 | US7253286 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective |
| 08/07/2007 | US7253284 Chemical compounds |
| 08/07/2007 | US7253281 2-(9-bromo-3,4,10,10a-tetrahydro-1H-pyrazino[1,2-a]indol-2-yl)-cyclobutanone; treating disorders of the central nervous system, damage to the central nervous system, cardiovascular disorders, gastrointestinal disorders, diabetes insipidus, obesity and sleep apnea |
| 08/07/2007 | US7253199 Azole derivatives and pharmaceutical compositions containing them |
| 08/07/2007 | US7253194 Compounds and inhibitors of phospholipases |
| 08/07/2007 | US7253191 2-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry |
| 08/07/2007 | US7253187 Heterocyclic inhibitors of ERK2 and uses thereof |
| 08/07/2007 | US7253183 Method of use of (imidazol-5-yl)methyl-2-quinolinone derivatives to inhibit smooth muscle cell proliferation |
| 08/07/2007 | US7253174 (Anilino)(halo)pyrimidine derivatives or (anilino)(amino)pyrimidine derivatives; treating rheumatoid arthritis, psoriasis, Crohn's Disease, osteoarthritis or osteoporosis. |
| 08/07/2007 | US7253172 Enzyme inhibitor for treating a non-insulin dependent diabetes mellitus; 3-Amino-4-(3,4-difluorophenyl)butanoyl]-4-[2-({3-[(methylsulfonyl)amino]-phenyl}-amino)-2-oxoethyl]piperazin-2-yl}acetic acid |
| 08/07/2007 | US7253171 Antiinflammatory agents; immunology diseases; multiple sclerosis; antihistamines; antidiabetic agents; vision defects; antiarthritic agents; skin disorders; antitumor agents |
| 08/07/2007 | US7253161 Cognition activators; neurodegenerative disease; anxiolytic agents; Alzheimer's diseas; Pick's disease; schizophrenia; psychological disorders; antiischemic agents; antiepileptic agents; antidepressants |
| 08/07/2007 | US7253157 Containing a diazacycloalkane ring, especially a 1,4-diazepane ring, e.g., N-p-((4-(alpha-phenylmethoxycarbonylmethyl)-1,4-diazepan-1-yl)phenyl)-o-biphenylcarboxamide, for the treatment of hyperlipidemia, obesity and type II diabetes. |
| 08/07/2007 | US7252934 Synergistic activation of regulatory elements by Rel proteins and a steroid receptor |
| 08/07/2007 | US7252819 Methods and compositions for correction of cardiac conduction disturbances |
| 08/07/2007 | US7252815 using carbocyanine dye; photodynamic therapy; supplying to tumor |
| 08/07/2007 | US7252799 Methods for sterilizing preparations containing albumin |
| 08/07/2007 | CA2802892A1 Composition for preventing recurrence of stroke |
| 08/07/2007 | CA2571462A1 Composition for preventing recurrence of stroke |
| 08/07/2007 | CA2376379C Modified chimeric polypeptides with improved pharmacokinetic properties |
| 08/07/2007 | CA2340636C Combinations of tetracyclic cyclic gmp-specific phosphodiesterase inhibitors with further therapeutic agents |
| 08/07/2007 | CA2333938C New 3-aryl-2-hydroxypropionic acid derivative (i) |
| 08/07/2007 | CA2332007C Adenosine a3 receptor modulators |
| 08/07/2007 | CA2317589C Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 08/07/2007 | CA2289196C Sustained-release delayed gels |
| 08/07/2007 | CA2266533C Pharmaceutical compositions comprising s-alkylisothiouronium derivatives |
| 08/07/2007 | CA2221689C Anti-ischaemic hydroxylamine derivatives and pharmaceutical compositions |
| 08/07/2007 | CA2207804C Amides of mono and bicarboxylic acids with amino acids or glycosamines, selectively active on the cannabinoid peripheral receptor |
| 08/07/2007 | CA2092718C Use of protective agents against reactive oxygen species |
| 08/02/2007 | WO2007087448A1 Spiro imidazole derivatives as ppar modulators |
| 08/02/2007 | WO2007087293A2 Mapc therapeutics without adjunctive immunosuppressive treatment |
| 08/02/2007 | WO2007087292A2 Mapc treatment of brain injuries and diseases |
| 08/02/2007 | WO2007087241A2 Treatment of ischemic disease using thrombopoietin |
| 08/02/2007 | WO2007087148A1 Crystalline forms of 3-biphenyl-4-yl-(2s)-[(4'-trifluoromethyl-biphenyl-4-carbonyl)-amino]-propionic acid, and methods of use |
| 08/02/2007 | WO2007086689A1 A solid dispersion comprising ubidecarenone, a process for preparing the same and a pharmaceutical composition comprising the same |
| 08/02/2007 | WO2007086663A1 Hif-1 alpha activating agent |
| 08/02/2007 | WO2007086584A1 NOVEL INHIBITOR OF FabK AND FabI/K |
| 08/02/2007 | WO2007086545A1 Method for screening cell function regulator |
| 08/02/2007 | WO2007086504A1 Carboxylic acid compound and use thereof |
| 08/02/2007 | WO2007086480A1 Composition for normalizing blood pressure |
| 08/02/2007 | WO2007086471A1 Process for production of lasofoxifene or analogue thereof |
| 08/02/2007 | WO2007086446A1 Pharmaceutical composition for prevention or treatment of cardiac failure |
| 08/02/2007 | WO2007086100A1 Composition having effect of lowering blood pressure and/or inhibiting increase in blood pressure and food and drink containing the same |
| 08/02/2007 | WO2007085413A2 Treatment of transient ischaemic attack |
| 08/02/2007 | WO2007085399A1 Use of a combination of valsartan and a calcium channel blocker in the treatment of insufficient blood flow and cerebral functional disorders |
| 08/02/2007 | WO2007085203A1 New substituted pentabasic azaheterocyclic compounds and its use of treating protein aging disease |
| 08/02/2007 | WO2007085202A1 Oxamic acid derivatives,preparation methods and medical uses thereof |
| 08/02/2007 | WO2007085127A1 A method for prognosing therapeutic effectiveness of acute angina pectoris with nitroglycerin and a kit therefor |
| 08/02/2007 | WO2007076127A3 Condensed imidazoles or pyrazoles and their use as transforming growth factor modulators |
| 08/02/2007 | WO2007068070A3 Composition containing an inhibitor of phosphodiesterase iii and a therapeutic alcohol for the treatment of atherosclerosis diseases |
| 08/02/2007 | WO2007065437A3 Modulation of the p2y2 receptor pathway |
| 08/02/2007 | WO2007052073A3 Heterocycle substituted amide and sulfur amide derivatives as histone deacetylase (hdac) inhibitors |
| 08/02/2007 | WO2007047724A3 Compositions for lowering serum cholesterol and/or triglycerides |
| 08/02/2007 | WO2007045927A3 Therapeutic agent |
| 08/02/2007 | WO2007042166A3 Egln2 variants and use thereof in preventing or treating thromboembolic disorders and coronary heart diseases |
| 08/02/2007 | WO2007017469A3 Process for preparing an angiotensin ii receptor antagonist |
| 08/02/2007 | US20070179601 Methods and apparatus for stenting comprising enhanced embolic protections coupled with improved protections against restenosis and trombus formation |
| 08/02/2007 | US20070179593 Methods and apparatus for stenting comprising enhanced embolic protection coupled with improved protecions against restenosis and thrombus formation |
| 08/02/2007 | US20070179297 Chemical compounds |
| 08/02/2007 | US20070179187 nor-seco himbacine derivatives; thrombosis, anticoagulants, anticancer agents; antiinflammatory agents; anticholesterol agents; cardiovascular disorders; antiarrhythmia agents; antiischemic agents; strokes; antiarthritic agents |
| 08/02/2007 | US20070179154 Coumarin derivatives, process for their production and use thereof |
| 08/02/2007 | US20070179139 Methyl 4-{[(2-{4-[(4-bromophenoxy)methyl]-2,5-dimethyl-3-thienyl}ethyl)(5-ethoxy-5-oxopentyl)amino]methyl}benzoate, for example; treatment of cardiovascular and other diseases |
| 08/02/2007 | US20070179118 Use as inhibitors of cyclin-dependent kinases 4 (cdk4); treating proliferative disorders such as cancer; salt of 6-acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-8H-pyrido[2,3-d]pyrimidin-7-one for example |
| 08/02/2007 | US20070179097 GnRH agonist combination drugs |
| 08/02/2007 | US20070178587 Method of culturing embryonic stem cells with the use of amniotic membrane-origin factor |
| 08/02/2007 | US20070178560 Measuring the energy transfer between fusion proteins comprising a leptin receptor and an energy donor protein ; bone disorders |
| 08/02/2007 | US20070178553 Mammalian T-type calcium channels |
| 08/02/2007 | US20070178174 Neuroprotective/neurostimulatory use of Cistanche extract |
| 08/02/2007 | US20070178118 Physiologically active composition and preparing method thereof |
| 08/02/2007 | DE102006002649A1 New aza-heterocycle compounds are tyrosine kinase inhibitors useful to treat and/or prevent e.g. cancer, tumor growth, tumor angiogenesis, arteriosclerosis, diabetic retinopathy and inflammation diseases |
| 08/02/2007 | CA2642887A1 Mapc therapeutics without adjunctive immunosuppressive treatment |
| 08/02/2007 | CA2642826A1 Mapc treatment of brain injuries and diseases |
| 08/02/2007 | CA2636426A1 Treatment of ischemic disease using thrombopoietin |
| 08/02/2007 | CA2627692A1 Spiro imidazole derivatives as ppar modulators |
| 08/01/2007 | EP1813671A1 Soluble protein and utilization of the same |
| 08/01/2007 | EP1813286A2 Pharmaceutical composition containing a compound having angiotensin II antagonistic activity in combination with another compound |
| 08/01/2007 | EP1813282A1 Remedy for angiospasm accompanying subarachnoid hemorrhage contianing thrombin receptor antagonist as the active ingredient |
| 08/01/2007 | EP1813269A1 TRANSCRIPTIONAL FACTOR Nrf2 ACTIVATOR AND FOOD HAVING THE FUNCTION OF THE SAME IMPARTED THERETO |
| 08/01/2007 | EP1812797A2 Compositions and methods for the treatment and prevention of hyperproliferative diseases |
| 08/01/2007 | EP1812474A2 Multi-domain amphipathic helical peptides and methods of their use |
| 08/01/2007 | EP1812451A2 Compounds and methods of use thereof |
| 08/01/2007 | EP1812430A1 Substituted phenylaminothiazoles and use thereof |
| 08/01/2007 | EP1812426A1 Aryl sulfonamide peri-substituted bicyclics for occlusive artery disease |
| 08/01/2007 | EP1812425A2 C-fms kinase inhibitors |
| 08/01/2007 | EP1812412A1 Substituted benzoylguanidines method for production and use thereof as medicament or diagnostic and medicament comprising the same |
| 08/01/2007 | EP1812388A1 Sulfonamide pert-substituted bicyclics for occlusive artery disease |
| 08/01/2007 | EP1812112A2 Chemical compounds |
| 08/01/2007 | EP1812043A1 Pharmaceutical preparation for the treatment of friedreich' s ataxia |
| 08/01/2007 | EP1812024A1 Bacterial compositions for prevention or treatment of atherosclerotic disorders |
| 08/01/2007 | EP1812006A2 Methods of using pde v inhibitors for the treatment of congestive heart failure |
| 08/01/2007 | EP1811840A2 Anti-tumor compounds with angeloyl groups |
| 08/01/2007 | EP1581505B1 Pyridazinone derivatives as gsk-3beta inhibitors |
| 08/01/2007 | EP1572071A4 Systems and methods for treating patients with processed lipoaspirate cells |
| 08/01/2007 | EP1556494B1 Bicistronic vector encoding a vegf and an fgf, use thereof |
| 08/01/2007 | EP1484327B1 Nitrogenous heterocyclic compound and medicine thereof |
| 08/01/2007 | EP1461038B1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 08/01/2007 | EP1419158B1 Pteridinone derivatives as modulators of chemokine receptor activity |
| 08/01/2007 | EP1381681B1 The nk1 fragment of hepatocyte growth factor/scatter factor (hgf/sf) and variants thereof, and their use |
| 08/01/2007 | EP1372681B1 Biologically active chloroform fraction of an extract obtained from a mangrove plant salvadora persica l |
| 08/01/2007 | EP1313715B1 Oxazolyl-aryloxyacetic acid derivatives and their use as ppar agonists |